Press releases

January 9, 2011 | Medication Management Systems and the American Society of Consultant Pharmacists Foundation Join Forces to Improve Drug Therapy Outcomes for Seniors

MINNEAPOLIS, MN (January 9, 2011) —Medication Management Systems, Inc. (MMS), a leader in medication therapy management (MTM), today announced a new partnership that makes available, for the first time, an integrated software documentation solution to more effectively manage drug therapies and positively impact the quality of life of millions of seniors in the community and long-term care.

February 9, 2010 | Triple-S Salud Selects Medication Management Systems, Inc. to deliver Medication Therapy Management Services in Puerto Rico

MINNEAPOLIS, MN (February 9, 2010) — Triple-S Salud, Inc. of Puerto Rico (Triple–S) has become the first health plan on the island of Puerto Rico to embrace the patient–centered medication therapy management (MTM) solutions provided by Medication Management Systems Puerto Rico, Inc., a wholly–owned subsidiary of Medication Management Systems, Inc.

December 15, 2009 | Prime Therapeutics selects Medication Management Systems to help manage MTM benefit for 1 million Medicare Part D members

MINNEAPOLIS, MN (Dec. 15, 2009) — Pharmacy benefit manager Prime Therapeutics LLC (Prime) is the latest Medicare Part D program administrator to embrace the comprehensive medication therapy management (MTM) service technology provided by Medication Management Systems, Inc. (MMS). Beginning Jan. 1, 2010, MMS’s Assurance System™ will support Prime’s MTM program to improve the safe and effective use of medications for nearly 1 million Blue Cross and Blue Shield members under Medicare Part D drug benefit plans administered by Prime. Read complete release >

July 29, 2009 | Linda Strand joins MMS

MINNEAPOLIS, MN (July 29, 2009)—Medication Management Systems, Inc. (MMS), one of the nation’s leaders in medication therapy management technology and services, announces the addition of Linda Strand, Pharm.D., Ph.D., D.Sc.(Hon) to its executive team. Read complete release >

April 27, 2009 | PMMS Expands to Canada

MINNEAPOLIS, MN (April 27, 2009)—A new U.S./Canadian cross-border partnership will expand access for patients who turn to pharmacists for medication therapy management services. Minneapolis-based Medication Management Systems, Inc. (MMS) has partnered with Medication Management Canada, Inc. (MMC) to adapt MMS’s groundbreaking electronic therapeutic record, the Assurance System™, for the Canadian health care market. Read complete release >

March 10, 2009 | MMS Client, General Mills, First to Adopt New Worksite Pharmacist Program

MINNEAPOLIS, MN (March 10, 2009)—To combat the growing complexity of drug therapies and improve the use of medications, General Mills is the first employer to offer on-site access to a new individualized care program through Medication Management Systems, Inc. (MMS). Read complete release >

March 18, 2008 | MTM Study Reports Improved Quality and Economic Outcomes: Using Medication Management Systems’ Assurance Pharmaceutical Care System™

MINNEAPOLIS, MN (March 18, 2008) — A landmark study published in the Journal of the American Pharmacists Association documents how medication therapy management (MTM) services, provided by experienced pharmacists using the Assurance Pharmaceutical Care System™, produced both improved clinical outcomes and lower total health care expenditures. Read complete release >

February 27, 2008 | Medication Management Systems Names New President and COO

MINNEAPOLIS, MN (February 27, 2008)—Medication Management Systems (MMS), a leading player in medication therapy management throughout the U.S., today announced the appointment of Nathan J. Schultz, Pharm.D. to the newly created executive position of President and Chief Operating Officer. Read complete release >

August 17, 2007| MMS Product Meets FDA Guidelines

MINNEAPOLIS, MN (August 17, 2007) Approximately 2 million Americans every year begin a prescribed regimen of the oral anticoagulant drug warfarin, according to the U.S. Food and Drug Administration (FDA). Marketed under a variety of brand labels, including Coumadin® and Jantoven®, this drug therapy treatment is prescribed to prevent blood clots and reduce the risk of heart attacks and strokes. Read complete release >

^Top